CLINICAL_TRIALS trial_result · 2014-05-29

Clinical Trial Update: CJD (Creutzfeldt-Jakob Disease) Quinacrine Study [Phase 2]

Phase 2 clinical trial evaluating Quinacrine for Creutzfeldt-Jakob Disease has completed and posted results. The results were posted on 2014-05-29.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of California, San Francisco | Conditions: Creutzfeldt-Jakob Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-05-29